Quantitative assessment of the graft versus host syndrome
Khaitov, R.M.
Biulleten' Eksperimental'noi Biologii i Meditsiny 73(10): 58-60
1972
ISSN/ISBN: 0365-9615 PMID: 4404542 Document Number: 54009
Document emailed within 1 workday
Related Documents
Nedelea, M.; Dima, S. 1975: Appearance of a syndrome similar to graft versus host reaction in C57 B1/6 mice bearing skin allogenic graft Morphologie et Embryologie 21(4): 299-304Hăsková, V.; Gansová, E. 1970: Quantitative aspects of graft-versus-host reaction in popliteal lymph node Folia Biologica 16(5): 314-319
Atkinson, K.; Storb, R.; Weiden, P.L.; Deeg, H.J.; Gerhard-Miller, L.; Thomas, E.D. 1980: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance Journal of Immunology 124(4): 1808-1814
Zaleski, M. 1971: Effect of host-versus-graft and graft-versus-host reactions on the immune response of mice to sheep red blood cells Folia Biologica 17(2): 111-122
Hess, A.D.; Vogelsang, G.B.; Heyd, J.; Beschorner, W.E. 1987: Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation Transplantation Proceedings 19(1 Part 3): 2683-2686
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
Carayol, G.; Bourhis, J.H.; Guillard, M.; Bosq, J.; Pailler, C.; Castagna, L.; Vernant, J.P.; Pico, J.L.; Hayat, M.; Chouaib, S.; Caignard, A. 1997: Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease Transplantation 63(9): 1307-1313
Vogel, J.H.; McFadden, R.B.; Spence, R.; Jahnke, E.J.; Love, J.W. 1978: Quantitative assessment of myocardial performance and graft patency following coronary bypass with the internal mammary artery Journal of Thoracic and Cardiovascular Surgery 75(4): 487-498
Mixon, B.; Mixon, J.; Isbey, E.K.; Sprinkle, S. 2014: Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report International Journal of Pharmaceutical Compounding 18(5): 370-377
Frezza, E.E.; Gerunda, G.E.; Fassina, A.; DeFranchis, R.; Biffi, R.; Gurakar, A.; Fagiuoli, S.; Maffei, F.A.; Van Thiel, D.H. 1994: NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation Transplantation Proceedings 26(3): 1626
You-Ten, K.E.; Lapp, W.S. 1996: The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease Transplantation 61(1): 76-83
Dey, B.; Yang, Y.G.; Preffer, F.; Shimizu, A.; Swenson, K.; Dombkowski, D.; Sykes, M. 1999: The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model Transplantation 68(1): 141-149
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
Cahn, J.Y.; Hervé, P.; Flesch, M.; Plouvier, E.; Racadot, E.; Montcuquet, P.; Noir, A.; Peters, A.; Leconte des Floris, R. 1986: T immunodepletion of the graft in allogeneic bone marrow grafts. Efficacy in the prevention of graft-versus-host reaction Presse Medicale 15(25): 1204
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Pegrum, G.D.; Williams, G.; Markwick, J.; Barnes, R.M. 1976: Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction Postgraduate Medical Journal 52(5 Suppl): 47-50